Clinical Trials Directory

Trials / Completed

CompletedNCT05278260

Hydrogen-rich Water and Treatment of Mucositis Caused by Radiation Therapy in Head and Neck Cancer Patients

Hydrogen Rich Water to Mitigate Acute Mucositis During Radiation Therapy

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Stony Brook University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study explores the effects of hydrogen-rich water on alleviating the radiation-induced acute mucositis in head and neck cancer patients

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTHydrogen tabletsParticipants will drink up to 1000 ml (34 fl. oz.) of water daily supplemented with a tablet that releases molecular hydrogen, for the duration of the radiation therapy
DIETARY_SUPPLEMENTControlParticipants will drink up to 1000 ml (34 fl. oz.) of water daily supplemented with a tablet that does not release any molecular hydrogen, for the duration of the radiation therapy

Timeline

Start date
2022-05-25
Primary completion
2024-11-13
Completion
2024-11-13
First posted
2022-03-14
Last updated
2025-05-14

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05278260. Inclusion in this directory is not an endorsement.

Hydrogen-rich Water and Treatment of Mucositis Caused by Radiation Therapy in Head and Neck Cancer Patients (NCT05278260) · Clinical Trials Directory